Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Morabito

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Science (New York, N.Y.)|August 3, 2019
A proof of concept for structure-based vaccine design targeting RSV in humansMichelle C Crank, Tracy J Ruckwardt, Man Chen, et al.
Science (New York, N.Y.)|October 7, 2016
Rapid development of a DNA vaccine for Zika virusKimberly A Dowd, Sung-Youl Ko, Kaitlyn M Morabito, et al.
Iscience|February 3, 2025
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodiesOlubukola M Abiona, Nianshuang Wang, Sarah R Leist, et al.
The New England Journal of Medicine|July 15, 2020
An mRNA Vaccine against SARS-CoV-2 - Preliminary ReportLisa A Jackson, Evan J Anderson, Nadine G Rouphael, et al.
Lancet (London, England)|December 9, 2017
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trialsMartin R Gaudinski, Katherine V Houser, Kaitlyn M Morabito, et al.
Immunity|April 6, 2021
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responsesMaryam Mukhamedova, Daniel Wrapp, Chen-Hsiang Shen, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S Corbett, Darin Edwards, Sarah R Leist, et al.
Nature|August 7, 2020
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparednessKizzmekia S Corbett, Darin K Edwards, Sarah R Leist, et al.
The New England Journal of Medicine|July 30, 2020
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman PrimatesKizzmekia S Corbett, Barbara Flynn, Kathryn E Foulds, et al.
Science (New York, N.Y.)|August 13, 2021
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Science (New York, N.Y.)|August 3, 2019
A proof of concept for structure-based vaccine design targeting RSV in humansMichelle C Crank, Tracy J Ruckwardt, Man Chen, et al.
Science (New York, N.Y.)|October 7, 2016
Rapid development of a DNA vaccine for Zika virusKimberly A Dowd, Sung-Youl Ko, Kaitlyn M Morabito, et al.
Iscience|February 3, 2025
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodiesOlubukola M Abiona, Nianshuang Wang, Sarah R Leist, et al.
The New England Journal of Medicine|July 15, 2020
An mRNA Vaccine against SARS-CoV-2 - Preliminary ReportLisa A Jackson, Evan J Anderson, Nadine G Rouphael, et al.
Lancet (London, England)|December 9, 2017
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trialsMartin R Gaudinski, Katherine V Houser, Kaitlyn M Morabito, et al.
Immunity|April 6, 2021
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responsesMaryam Mukhamedova, Daniel Wrapp, Chen-Hsiang Shen, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S Corbett, Darin Edwards, Sarah R Leist, et al.
Nature|August 7, 2020
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparednessKizzmekia S Corbett, Darin K Edwards, Sarah R Leist, et al.
The New England Journal of Medicine|July 30, 2020
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman PrimatesKizzmekia S Corbett, Barbara Flynn, Kathryn E Foulds, et al.
Science (New York, N.Y.)|August 13, 2021
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, et al.
Pageof 9